Inventor · Berkeley, CA, US

Brooks Boyd

21Patents
8h-index
16Co-inventors
72Inventor score

Filing activity: May 31, 2002 → Apr 5, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8734384B2 Needle-free injectors and design parameters thereof that optimize injection performance Human Necessities 12 Active
US10682317B2 Ketogenic diet compatible fenfluramine formulation Human Necessities 10 Active
US10603290B2 Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Human Necessities 10 Active
US11040018B2 Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Human Necessities 10 Active
US10689324B2 Metabolism resistant fenfluramine analogs and methods of using the same Chemistry; Metallurgy 10 Active
US9186461B2 Viscous formulations and their use in needle-free injection Human Necessities 9 Active
US8876758B2 Viscous formulations and their use in needle-free injection Human Necessities 9 Active
US8066661B2 Viscous formulations and their use in needle-free injection Human Necessities 9 Active
US9737605B2 Injectable controlled release composition comprising high viscosity liquid carrier Human Necessities 7 Active
US11406606B2 Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Human Necessities 5 Active
US11458111B2 Ketogenic diet compatible fenfluramine formulation Human Necessities 5 Active
US11325882B2 Metabolism resistant fenfluramine analogs and methods of using the same Chemistry; Metallurgy 4 Active
US10226532B2 Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material Human Necessities 2 Active
US9572812B2 Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material Human Necessities 2 Active
US11786487B2 Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Human Necessities 2 Active
US11673852B2 Metabolism resistant fenfluramine analogs and methods of using the same Chemistry; Metallurgy 2 Active
US11759440B2 Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Human Necessities 2 Active
US9265888B2 Needle-free injectors and design parameters thereof that optimize injection performance Human Necessities 1 Active
US6830744B2 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b Human Necessities 0 Expired
US11285217B2 Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material Human Necessities 0 Active
US9662449B2 Needle-free injectors and design parameters thereof that optimize injection performance Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.